F Sciarra

1.1k total citations
58 papers, 873 citations indexed

About

F Sciarra is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F Sciarra has authored 58 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Reproductive Medicine and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F Sciarra's work include Hormonal and reproductive studies (31 papers), Prostate Cancer Treatment and Research (12 papers) and Sexual Differentiation and Disorders (9 papers). F Sciarra is often cited by papers focused on Hormonal and reproductive studies (31 papers), Prostate Cancer Treatment and Research (12 papers) and Sexual Differentiation and Disorders (9 papers). F Sciarra collaborates with scholars based in Italy, Belgium and United States. F Sciarra's co-authors include F. Di Silverio, Vincenzo Toscano, Salvatore Monti, G Concolino, G D'Eramo, Eleonora Palma, Elisa Petrangeli, Carla Lubrano, R Balducci and C Conti and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Cancer and European Urology.

In The Last Decade

F Sciarra

53 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Sciarra Italy 19 458 275 228 211 169 58 873
Hosea F. S. Huang United States 20 108 0.2× 273 1.0× 47 0.2× 357 1.7× 51 0.3× 32 834
L. Seethalakshmi United States 15 161 0.4× 175 0.6× 54 0.2× 292 1.4× 42 0.2× 33 727
Maryam Razzaghy‐Azar Iran 16 537 1.2× 489 1.8× 34 0.1× 54 0.3× 74 0.4× 44 981
N. Brust United States 9 565 1.2× 376 1.4× 115 0.5× 42 0.2× 20 0.1× 12 781
Andrea Repaci Italy 18 556 1.2× 181 0.7× 46 0.2× 425 2.0× 14 0.1× 51 1.1k
Ognjen Kraus Croatia 12 182 0.4× 233 0.8× 145 0.6× 11 0.1× 63 0.4× 43 631
M T Tusié-Luna Mexico 9 897 2.0× 933 3.4× 22 0.1× 27 0.1× 180 1.1× 11 1.2k
Jean‐Marc Husson France 6 256 0.6× 76 0.3× 185 0.8× 59 0.3× 4 0.0× 8 576
Ashley M. Bunker United States 11 540 1.2× 426 1.5× 84 0.4× 111 0.5× 3 0.0× 12 1.2k
Joaquina Silva Portugal 20 69 0.2× 250 0.9× 84 0.4× 521 2.5× 9 0.1× 42 938

Countries citing papers authored by F Sciarra

Since Specialization
Citations

This map shows the geographic impact of F Sciarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Sciarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Sciarra more than expected).

Fields of papers citing papers by F Sciarra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Sciarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Sciarra. The network helps show where F Sciarra may publish in the future.

Co-authorship network of co-authors of F Sciarra

This figure shows the co-authorship network connecting the top 25 collaborators of F Sciarra. A scholar is included among the top collaborators of F Sciarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Sciarra. F Sciarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sciarra, Luigi, et al.. (2024). Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation. Frontiers in Pharmacology. 15. 1384213–1384213. 4 indexed citations
2.
Cardillo, Maria Rosaria, Salvatore Monti, F. Di Silverio, et al.. (2003). Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.. IRIS Research product catalog (Sapienza University of Rome). 23(5A). 3825–35. 76 indexed citations
3.
Stigliano, Antonio, S. Caiola, Ester Siniscalchi, et al.. (2001). Mutational analysis of StAR gene in adrenal tumors. International Journal of Cancer. 97(3). 357–360. 1 indexed citations
4.
Monti, Salvatore, F. Di Silverio, Chiara Martini, et al.. (2001). Regional Variations of Insulin-Like Growth Factor I (IGF-I), IGF-II, and Receptor Type 1 in Benign Prostatic Hyperplasia Tissue and Their Correlation with Intraprostatic Androgens1. The Journal of Clinical Endocrinology & Metabolism. 86(4). 1700–1706. 33 indexed citations
5.
6.
Toscano, Vincenzo, et al.. (1998). Hyperandrogenism in the Adolescent Female. Steroids. 63(5-6). 308–313. 6 indexed citations
7.
Ghirri, Paolo, Terry R. Brown, Antonio Boldrini, et al.. (1996). A clinician looks at androgen resistance. Steroids. 61(4). 205–211. 17 indexed citations
8.
9.
Sciarra, F, Salvatore Monti, Eleonora Palma, et al.. (1995). Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue. Urological Research. 23(6). 387–390. 16 indexed citations
10.
Toscano, Vincenzo, et al.. (1993). Two different pathogenetic mechanisms may play a role in acne and in hirsutism. Clinical Endocrinology. 39(5). 551–556. 31 indexed citations
11.
Lubrano, Carla, F Sciarra, Enrico Spera, et al.. (1992). Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 683–687. 19 indexed citations
12.
Toscano, Vincenzo, R Balducci, Paola Bianchi, et al.. (1992). Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. The Journal of Steroid Biochemistry and Molecular Biology. 43(5). 431–437. 54 indexed citations
13.
Silverio, F. Di, G D'Eramo, Carla Lubrano, et al.. (1992). Evidence that Serenoa repens Extract Displays an Antiestrogenic Activity in Prostatic Tissue of Benign Prostatic Hypertrophy Patients. European Urology. 21(4). 309–314. 82 indexed citations
14.
Sciarra, F, Vincenzo Toscano, G Concolino, & F. Di Silverio. (1990). Antiandrogens: Clinical applications. The Journal of Steroid Biochemistry and Molecular Biology. 37(3). 349–362. 28 indexed citations
15.
Silverio, F. Di, F Sciarra, & G D'Eramo. (1990). Advanced Prostatic Cancer: Clinical and Hormonal Response to Flutamide in Patients Pretreated with LHRH Analogue andCyproterone Acetate. European Urology. 18(1). 10–15. 8 indexed citations
16.
Lubrano, Carla, Elisa Petrangeli, Angela Catizone, et al.. (1989). Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia. Journal of Steroid Biochemistry. 34(1-6). 499–504. 22 indexed citations
17.
Sciarra, F. (1988). Anti-estrogens and aromatase inhibitors: Tamoxifen and testolactone. Journal of Endocrinological Investigation. 11(10). 755–762. 4 indexed citations
18.
Sulon, J., et al.. (1978). 24 HOUR PROFILE OF 18‐HYDROXY‐11‐DEOXYCORTICOSTERONE IN NORMAL SUPINE MAN: RELATIONSHIP WITH CORTISOL AND ALDOSTERONE. Clinical Endocrinology. 8(5). 367–372. 4 indexed citations
19.
Dondero, Francesco, F Sciarra, & Andrea M. Isidori. (1972). Evaluation of Relationship between Plasma Testosterone and Human Seminal Citric Acid. Fertility and Sterility. 23(3). 168–171. 18 indexed citations
20.
Concolino, G, et al.. (1969). Plasma estrogens in bilateral gynecomastia.. PubMed. 22(2). 179–89. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hosea F. S. Huang Breakdown of academic impact, for papers by L. Seethalakshmi Breakdown of academic impact, for papers by Maryam Razzaghy‐Azar Breakdown of academic impact, for papers by N. Brust Breakdown of academic impact, for papers by Andrea Repaci Breakdown of academic impact, for papers by Ognjen Kraus Breakdown of academic impact, for papers by M T Tusié-Luna Breakdown of academic impact, for papers by Jean‐Marc Husson Breakdown of academic impact, for papers by Ashley M. Bunker Breakdown of academic impact, for papers by Joaquina Silva
Rankless by CCL
2026